Ublituximab (Briumvi) for Relapsing Multiple Sclerosis

[Anonymous]

MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023; 65 (1671): 36

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索